Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study

Go back to Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study
(AMEX: TDSGF) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High $0.84 
Open $0.03    52 Week Low $0.60 
Day High $0.03    P/E N/A 
Day Low $0.03    EPS $0.00 
Volume 91,135